بحث

The purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant endocrine therapy (ET) on invasive breast cancer-free survival (iBCFS), in a close to clinical practice patient population with…

✓ جهة الاتصال✗ مُطالب به

📍 أقرب مركز: Wichita, Kansas, United States — على بُعد 43 كم · 229 مراكز إجمالاً · جهة اتصال مُدرجة

This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T-cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study. Participants who received at least o…

✓ جهة الاتصال✗ مُطالب به

📍 أقرب مركز: Wichita, Kansas, United States — على بُعد 43 كم · 222 مراكز إجمالاً · جهة اتصال مُدرجة

This is a two-part, Phase I/II, open-label, global, multicenter study assessing the safety and efficacy of the combination of tulmimetostat (DZR123) and JSB462 (luxdegalutamide) versus standard of care in participants with progressive metastatic castrate resistant prostate cancer (mCRPC).

✓ جهة الاتصال✗ مُطالب به

📍 أقرب مركز: Wichita, Kansas, United States — على بُعد 43 كم · 35 مراكز إجمالاً · جهة اتصال مُدرجة

The purpose of this study is to evaluate whether zilebesiran versus placebo reduces the risk of cardiovascular (CV) death, nonfatal myocardial infarction (MI), nonfatal stroke, or heart failure (HF) events. This is an event-driven study that will continue until the targeted number of positively adju…

✓ جهة الاتصال✗ مُطالب به

📍 أقرب مركز: Hutchinson, Kansas, United States — على بُعد 36 كم · 1,153 مراكز إجمالاً

PODOMOUNT-pFSGS This study is open to adults and adolescents with a kidney condition called focal segmental glomerulosclerosis (FSGS). The purpose of this study is to find out whether a medicine called BI 764198 helps people with FSGS. Participants are put into 2 groups randomly, which means by ch…

✓ جهة الاتصال✗ مُطالب به

📍 أقرب مركز: Wichita, Kansas, United States — على بُعد 43 كم · 307 مراكز إجمالاً · جهة اتصال مُدرجة

This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) in combination with pembrolizumab compared to treatment of physician's choice (TPC) in participants with triple-negative breast cancer (TNBC) who received neoadjuvant therapy and di…

✓ جهة الاتصال✗ مُطالب به

📍 أقرب مركز: Wichita, Kansas, United States — على بُعد 43 كم · 311 مراكز إجمالاً

This study is open to adults with chronic kidney disease at risk of progression. People with and without type 2 diabetes can take part in this study. The study is open to people who take other medicines called angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB). Pe…

✓ جهة الاتصال✗ مُطالب به

📍 أقرب مركز: Wichita, Kansas, United States — على بُعد 43 كم · 557 مراكز إجمالاً · جهة اتصال مُدرجة

This trial will examine if maridebart cafraglutide as an adjunct to standard of care will lead to a reduction in heart failure (HF) events such as HF hospitalizations and urgent HF visits, cardiovascular (CV) deaths and improvement in HF symptoms in participants with HF with preserved ejection fract…

✓ جهة الاتصال✗ مُطالب به

📍 أقرب مركز: Wichita, Kansas, United States — على بُعد 43 كم · 657 مراكز إجمالاً

This Phase III, multicenter, double-blind, placebo-controlled treat-through study will evaluate the efficacy and safety of induction and maintenance therapy with Afimkibart (also known as RO7790121) in participants with moderately to severely active Crohn's disease (CD).

✓ جهة الاتصال✗ مُطالب به

📍 أقرب مركز: Wichita, Kansas, United States — على بُعد 43 كم · 374 مراكز إجمالاً

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empaglifl…

✓ جهة الاتصال✗ مُطالب به

📍 أقرب مركز: Wichita, Kansas, United States — على بُعد 43 كم · 1,143 مراكز إجمالاً · جهة اتصال مُدرجة

The Phase 2 portion of this study evaluates the efficacy and safety of MRTX849 monotherapy and in combination with pembrolizumab in cohorts of patients with advanced NSCLC with KRAS G12C mutation and any PD-L1 TPS and who are candidates for first-line treatment. The Phase 3 portion of the study com…

✓ جهة الاتصال✗ مُطالب به

📍 أقرب مركز: Kingman, Kansas, United States — على بُعد 28 كم · 770 مراكز إجمالاً · جهة اتصال مُدرجة

Ulcerative Colitis (UC) and Crohn's Disease (CD) are long-term conditions in the gut that can cause diarrhea, swelling (inflammation), bleeding from the anus, and belly pain. The main aim of this study is to check for how many participants with UC and CD signs and symptoms disappear after 3.5 months…

✓ جهة الاتصال✗ مُطالب به

📍 أقرب مركز: Hutchinson, Kansas, United States — على بُعد 36 كم · 101 مراكز إجمالاً · جهة اتصال مُدرجة

Study comparing efficacy and safety of olverembatinib (investigational arm) vs. bosutinib (control arm) in patients with CML-CP (Part A). Study will also evaluate efficacy and safety of olverembatinib (single-arm) in CML-CP patients with T315I mutation (Part B). Patients who meet ELN 2025 failure c…

✓ جهة الاتصال✗ مُطالب به

📍 أقرب مركز: Wichita, Kansas, United States — على بُعد 43 كم · 163 مراكز إجمالاً

The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence.

✓ جهة الاتصال✗ مُطالب به

📍 أقرب مركز: Wichita, Kansas, United States — على بُعد 43 كم · 567 مراكز إجمالاً · جهة اتصال مُدرجة

The field of transcatheter tricuspid valve replacement (TTVR) is rapidly emerging and data on this topic are scarce. Particularly, little is known about which patients are at greatest risk of procedural complications, such as the timing and onset of conduction disturbances necessitating permanent pa…

✓ جهة الاتصال✗ مُطالب به

📍 أقرب مركز: Wichita, Kansas, United States — على بُعد 43 كم · 31 مراكز إجمالاً

The study aims to evaluate an egg-based H5N8 influenza vaccine up to 3 dose levels (low, medium, and high dose) given with or without adjuvant to see if the adjuvant improves vaccine effectiveness. The study will enroll healthy adults aged 18 years and over. Participants will receive 2 injections i…

✓ جهة الاتصال✗ مُطالب به

📍 أقرب مركز: Newton, Kansas, United States — على بُعد 53 كم · 16 مراكز إجمالاً

Participants include men and women ≥ 40 years of age with T2DM, established CV disease, a history of HTN with an SBP of at least 130 mmHg at screening, who meet the predefined serum potassium level, and with at least one additional risk factor for HF. The study will include an optional pre-screenin…

✓ جهة الاتصال✗ مُطالب به

📍 أقرب مركز: Wichita, Kansas, United States — على بُعد 43 كم · 957 مراكز إجمالاً

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Migraine is extremely common and disabling in children. The purpose of this study is to evaluate how sa…

✓ جهة الاتصال✗ مُطالب به

📍 أقرب مركز: Wichita, Kansas, United States — على بُعد 43 كم · 129 مراكز إجمالاً

This is a Phase 2/3 study evaluating the safety and efficacy of DM199 (rinvecalinase alfa) in treating participants with moderate stroke severity, who present within 24 hours of Acute Ischemic Stroke (AIS) onset due to small and medium vessel occlusions. This study focuses on participants with limit…

✓ جهة الاتصال✗ مُطالب به

📍 أقرب مركز: Wichita, Kansas, United States — على بُعد 43 كم · 86 مراكز إجمالاً · جهة اتصال مُدرجة

The overall objective of the RESTORATiVE303 study is to evaluate the safety and the Clostridioides difficile infection (CDI) recurrence rate at Week 8 in participants who receive a 14-day course of VE303 or matching placebo. The objectives and endpoints are identical for Stage 1 (recurrent CDI) and…

✓ جهة الاتصال✗ مُطالب به

📍 أقرب مركز: Wichita, Kansas, United States — على بُعد 43 كم · 215 مراكز إجمالاً

This study is researching an experimental drug called REGN7508 (called "study drug") and how it compares against another treatment called Acetylsalicylic Acid (ASA). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement surgery. The aim of the study is to…

✓ جهة الاتصال✗ مُطالب به

📍 أقرب مركز: Wichita, Kansas, United States — على بُعد 43 كم · 36 مراكز إجمالاً

The purpose of this study is to compare the efficacy of Nivolumab and Relatlimab in combination with chemotherapy to Pembrolizumab with Chemotherapy in participants with stage IV or recurrent Non-squamous Non-small Cell Lung Cancer with PD-L1 expression ≥ 1%

✓ جهة الاتصال✗ مُطالب به

📍 أقرب مركز: Wichita, Kansas, United States — على بُعد 43 كم · 326 مراكز إجمالاً · جهة اتصال مُدرجة

The aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.

✓ جهة الاتصال✗ مُطالب به

📍 أقرب مركز: Wichita, Kansas, United States — على بُعد 43 كم · 34 مراكز إجمالاً · جهة اتصال مُدرجة

This is a Phase III, international, multi-centre, randomised, double-blind, parallel-group, double-dummy, active-controlled, event-driven study in patients with chronic HF and impaired kidney function who had a recent HF event. The aim is to evaluate the effect of balcinrenone/dapagliflozin vs dapag…

✓ جهة الاتصال✗ مُطالب به

📍 أقرب مركز: Wichita, Kansas, United States — على بُعد 43 كم · 852 مراكز إجمالاً

This is a study to evaluate the effect on LDL-C and the safety and tolerability of FDC laroprovstat/rosuvastatin in LLT-naïve patients. Laroprovstat is a small molecule that reduces the amount of LDL-C in the blood. Laroprovstat and FDC laroprovstat/rosuvastatin are being developed for the treatment…

✓ جهة الاتصال✗ مُطالب به

📍 أقرب مركز: Derby, Kansas, United States — على بُعد 54 كم · 152 مراكز إجمالاً